✦ LIBER ✦

Significance of secondary cytogenetic changes in patients with Ph-positive chronic granulocytic leukemia in the acute phase

✍ Scribed by Sardool Singh; Jane Wass; Paul C. Vincent; Graham A.R. Young; Frederick W. Gunz

Book ID: 119103138
Publisher: Elsevier Science
Year: 1986
Tongue: English
Weight: 593 KB
Volume: 21
Category: Article
ISSN: 0165-4608
DOI: 10.1016/0165-4608(86)90002-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic significance of secondary cyt

Prognostic significance of secondary cytogenetic changes and nonspecific cross-reacting antigen (NCA) in patients with Ph-positive chronic myeloid leukemia

✍ O. Haus; A. Noworolska; M. Laskowski; M. Kuliszkiewicz-Janus; J. Kozłowska; A. H 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 581 KB

Cytogenetic studies in blast crisis of P

Cytogenetic studies in blast crisis of Ph-positive chronic granulocytic leukemia: Results and prognostic evaluation in 52 patients

✍ Francisco Cervantes; Francisca Ballesta; Montserrat Mila; Ciril Rozman 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 414 KB

The clinical and cytogenetic significanc

The clinical and cytogenetic significance of C-banding on chromosome #9 in patients with Ph1-positive chronic myeloid leukemia

✍ Naoki Sadamori; Avery A. Sandberg 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 580 KB

Early transformation to acute myeloblast

Early transformation to acute myeloblastic leukaemia with the acquisition of inv(16) in Ph positive chronic granulocytic leukaemia

✍ H. Myint; F.M. Ross; J.L. Hall; T.J. Hamblin 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 216 KB

The significance of myelosuppression dur

The significance of myelosuppression during therapy with imatinib mesylate in patients with chronic myelogenous leukemia in chronic phase

✍ Thomas B. Sneed; Hagop M. Kantarjian; Moshe Talpaz; Susan O'Brien; Mary Beth Rio 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 1 views

## Abstract ## BACKGROUND Imatinib mesylate induces high rates of hematologic and cytogenetic response in patients with chronic myelogenous leukemia (CML). During therapy with imatinib, up to 45% of patients with CML reportedly experience myelosuppression ≥ Grade 3, requiring interruption of thera

Chromosome changes in a patient achievin

Chromosome changes in a patient achieving complete remission in the acute phase of chronic myelogenous leukemia

✍ Ronald Stern; Julie Sorenson; Doris H. Wurster-Hill; Gibbons G. Cornwell III; O. 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 449 KB 👁 2 views